Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Chemical Reversion of Conventional Human Pluripotent Stem Cells to a Naïve-like State with Improved Multilineage Differentiation Potency.

Park TS, Zimmerlin L, Evans-Moses R, Zambidis ET.

J Vis Exp. 2018 Jun 10;(136). doi: 10.3791/57921.

PMID:
29939183
2.

Capturing Human Naïve Pluripotency in the Embryo and in the Dish.

Zimmerlin L, Park TS, Zambidis ET.

Stem Cells Dev. 2017 Aug 15;26(16):1141-1161. doi: 10.1089/scd.2017.0055. Epub 2017 Jun 26. Review.

PMID:
28537488
3.

Tankyrase inhibition promotes a stable human naïve pluripotent state with improved functionality.

Zimmerlin L, Park TS, Huo JS, Verma K, Pather SR, Talbot CC Jr, Agarwal J, Steppan D, Zhang YW, Considine M, Guo H, Zhong X, Gutierrez C, Cope L, Canto-Soler MV, Friedman AD, Baylin SB, Zambidis ET.

Development. 2016 Dec 1;143(23):4368-4380. Epub 2016 Sep 22.

4.

Dynamic Interactions Between Cancer Stem Cells And Their Stromal Partners.

Park TS, Donnenberg VS, Donnenberg AD, Zambidis ET, Zimmerlin L.

Curr Pathobiol Rep. 2014 Mar 1;2(1):41-52.

5.

Vascular progenitors from cord blood-derived induced pluripotent stem cells possess augmented capacity for regenerating ischemic retinal vasculature.

Park TS, Bhutto I, Zimmerlin L, Huo JS, Nagaria P, Miller D, Rufaihah AJ, Talbot C, Aguilar J, Grebe R, Merges C, Reijo-Pera R, Feldman RA, Rassool F, Cooke J, Lutty G, Zambidis ET.

Circulation. 2014 Jan 21;129(3):359-72. doi: 10.1161/CIRCULATIONAHA.113.003000. Epub 2013 Oct 25.

6.

Cellular kinetics of perivascular MSC precursors.

Chen WC, Park TS, Murray IR, Zimmerlin L, Lazzari L, Huard J, Péault B.

Stem Cells Int. 2013;2013:983059. doi: 10.1155/2013/983059. Epub 2013 Aug 19. Review.

7.

Mesenchymal stem cell secretome and regenerative therapy after cancer.

Zimmerlin L, Park TS, Zambidis ET, Donnenberg VS, Donnenberg AD.

Biochimie. 2013 Dec;95(12):2235-45. doi: 10.1016/j.biochi.2013.05.010. Epub 2013 Jun 5. Review.

8.

KIT (CD117) expression in a subset of non-small cell lung carcinoma (NSCLC) patients.

Donnenberg AD, Zimmerlin L, Landreneau RJ, Luketich JD, Donnenberg VS.

PLoS One. 2012;7(12):e52885. doi: 10.1371/journal.pone.0052885. Epub 2012 Dec 20.

9.

Human adipose stromal vascular cell delivery in a fibrin spray.

Zimmerlin L, Rubin JP, Pfeifer ME, Moore LR, Donnenberg VS, Donnenberg AD.

Cytotherapy. 2013 Jan;15(1):102-8. doi: 10.1016/j.jcyt.2012.10.009.

10.

Mesenchymal markers on human adipose stem/progenitor cells.

Zimmerlin L, Donnenberg VS, Rubin JP, Donnenberg AD.

Cytometry A. 2013 Jan;83(1):134-40. doi: 10.1002/cyto.a.22227. Epub 2012 Nov 26.

11.

Growth factor-activated stem cell circuits and stromal signals cooperatively accelerate non-integrated iPSC reprogramming of human myeloid progenitors.

Park TS, Huo JS, Peters A, Talbot CC Jr, Verma K, Zimmerlin L, Kaplan IM, Zambidis ET.

PLoS One. 2012;7(8):e42838. doi: 10.1371/journal.pone.0042838. Epub 2012 Aug 8.

12.

Efficient and simultaneous generation of hematopoietic and vascular progenitors from human induced pluripotent stem cells.

Park TS, Zimmerlin L, Zambidis ET.

Cytometry A. 2013 Jan;83(1):114-26. doi: 10.1002/cyto.a.22090. Epub 2012 Jun 26.

13.

Pericytes: a universal adult tissue stem cell?

Zimmerlin L, Donnenberg VS, Donnenberg AD.

Cytometry A. 2012 Jan;81(1):12-4. doi: 10.1002/cyto.a.21168. Epub 2011 Nov 8. No abstract available.

14.

Development and validation of a procedure to isolate viable bone marrow cells from the vertebrae of cadaveric organ donors for composite organ grafting.

Gorantla VS, Schneeberger S, Moore LR, Donnenberg VS, Zimmerlin L, Lee WP, Donnenberg AD.

Cytotherapy. 2012 Jan;14(1):104-13. doi: 10.3109/14653249.2011.605350. Epub 2011 Sep 12.

15.

Adipogenic potential of adipose stem cell subpopulations.

Li H, Zimmerlin L, Marra KG, Donnenberg VS, Donnenberg AD, Rubin JP.

Plast Reconstr Surg. 2011 Sep;128(3):663-72. doi: 10.1097/PRS.0b013e318221db33.

16.
17.

Placental perivascular cells for human muscle regeneration.

Park TS, Gavina M, Chen CW, Sun B, Teng PN, Huard J, Deasy BM, Zimmerlin L, Péault B.

Stem Cells Dev. 2011 Mar;20(3):451-63. doi: 10.1089/scd.2010.0354. Epub 2010 Nov 30.

18.

Regenerative therapy after cancer: what are the risks?

Donnenberg VS, Zimmerlin L, Rubin JP, Donnenberg AD.

Tissue Eng Part B Rev. 2010 Dec;16(6):567-75. doi: 10.1089/ten.TEB.2010.0352. Epub 2010 Nov 2. Review.

19.

Regenerative therapy and cancer: in vitro and in vivo studies of the interaction between adipose-derived stem cells and breast cancer cells from clinical isolates.

Zimmerlin L, Donnenberg AD, Rubin JP, Basse P, Landreneau RJ, Donnenberg VS.

Tissue Eng Part A. 2011 Jan;17(1-2):93-106. doi: 10.1089/ten.TEA.2010.0248. Epub 2010 Sep 17.

20.

Localization of CD44 and CD90 positive cells to the invasive front of breast tumors.

Donnenberg VS, Donnenberg AD, Zimmerlin L, Landreneau RJ, Bhargava R, Wetzel RA, Basse P, Brufsky AM.

Cytometry B Clin Cytom. 2010 Sep;78(5):287-301. doi: 10.1002/cyto.b.20530. Epub 2010 Apr 30.

21.

Stromal vascular progenitors in adult human adipose tissue.

Zimmerlin L, Donnenberg VS, Pfeifer ME, Meyer EM, Péault B, Rubin JP, Donnenberg AD.

Cytometry A. 2010 Jan;77(1):22-30. doi: 10.1002/cyto.a.20813. Erratum in: Cytometry A. 2010 Apr;77(4):406.

Supplemental Content

Loading ...
Support Center